Avalo Therapeutics Ord shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Avalo Therapeutics Ord
Tip: Access up to 7 years of quarterly data
All positions including Avalo Therapeutics Ord held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avalo Therapeutics Ord by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.2M | 65k | 18.16 |